NKTR-214, an Engineered Cytokine with Biased IL2 Receptor Binding, Increased Tumor Exposure, and Marked Efficacy in Mouse Tumor Models

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Deborah H CharychStephen K Doberstein

Abstract

Aldesleukin, recombinant human IL2, is an effective immunotherapy for metastatic melanoma and renal cancer, with durable responses in approximately 10% of patients; however, severe side effects limit maximal dosing and thus the number of patients able to receive treatment and potential cure. NKTR-214 is a prodrug of conjugated IL2, retaining the same amino acid sequence as aldesleukin. The IL2 core is conjugated to 6 releasable polyethylene glycol (PEG) chains. In vivo, the PEG chains slowly release to generate active IL2 conjugates. We evaluated the bioactivity and receptor binding of NKTR-214 and its active IL2 conjugates in vitro; the tumor immunology, tumor pharmacokinetics, and efficacy of NKTR-214 as a single agent and in combination with anti-CTLA-4 antibody in murine tumor models. Tolerability was evaluated in non-human primates. In a murine melanoma tumor model, the ratio of tumor-killing CD8(+) T cells to Foxp3(+) regulatory T cells was greater than 400 for NKTR-214 compared with 18 for aldesleukin, supporting preferential activation of the IL2 receptor beta over IL2 receptor alpha, due to the location of PEG molecules. NKTR-214 provides a 500-fold greater exposure of the tumor to conjugated IL2 compared with aldesleu...Continue Reading

References

Aug 1, 1994·Immunity·T L WalunasJ A Bluestone
Mar 22, 1996·Science·D R LeachJ P Allison
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M B AtkinsS A Rosenberg
Jun 4, 2005·Science·Mathias RickertK Christopher Garcia
Feb 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Deborah J StauberIan A Wilson
Jun 17, 2006·The Journal of Clinical Investigation·Sergio A QuezadaJames P Allison
Sep 21, 2006·Clinical Pharmacokinetics·Suphiya Parveen, Sanjeeb K Sahoo
Jun 5, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kim MargolinBrian Schwartz
Jan 18, 2008·Journal of Pharmaceutical Sciences·C Simone Fishburn
Mar 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John A ThompsonDiana F Hausman
Sep 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Franz O SmithSteven A Rosenberg
Sep 9, 2008·Expert Opinion on Biological Therapy·Kim Margolin
Feb 4, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Penghui ZhouPan Zheng
Feb 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Michael A CurranJames P Allison
Jun 16, 2010·Proceedings of the National Academy of Sciences of the United States of America·Carsten KriegOnur Boyman
May 3, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stephen D GilliesKin-Ming Lo
Feb 22, 2012·Nature Reviews. Immunology·Onur Boyman, Jonathan Sprent
Mar 31, 2012·Science Translational Medicine·Steven A Rosenberg
May 24, 2012·The Annals of Pharmacotherapy·Jai N Patel, Christine M Walko
Apr 13, 2013·Current Opinion in Immunology·Thomas F GajewskiStefani Spranger
Jun 4, 2013·The New England Journal of Medicine·Jedd D WolchokMario Sznol
Oct 4, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Patrick A OttCaroline Robert
Jan 16, 2015·The Oncologist·Bruce A Chabner

❮ Previous
Next ❯

Citations

Nov 12, 2016·Trends in Pharmacological Sciences·James R KintzingJennifer R Cochran
Feb 7, 2017·Expert Review of Anticancer Therapy·Inês Anselmo Da CostaJens Bedke
Sep 21, 2017·Expert Opinion on Drug Safety·Stephen Marabondo, Howard L Kaufman
Jan 10, 2018·Frontiers in Immunology·Isabel Corraliza-GorjónLeonor Kremer
Jun 8, 2018·Expert Review of Anticancer Therapy·Jason M Redman, Ravi A Madan
Jun 7, 2018·Oncoimmunology·Elena García-MartínezLorenzo Galluzzi
Sep 14, 2018·Nature Reviews. Immunology·Laura ChiossoneEric Vivier
Oct 30, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas Powles, Brian Rini
Feb 27, 2019·Current Oncology Reports·Michael Lattanzi, Arjun V Balar
Mar 9, 2019·Current Oncology Reports·Bryden Considine, Michael E Hurwitz
Jun 8, 2019·Expert Opinion on Biological Therapy·Iris Y Sheng, Brian I Rini
Dec 9, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Seth M PollackGary K Schwartz
Sep 22, 2019·International Journal of Molecular Sciences·Bilikis Aderonke AbolarinwaYen-Hua Huang
Jan 24, 2020·Journal of Cellular Physiology·Ghasem Rahimi Kalateh Shah MohammadSeyed Isaac Hashemy
Jan 9, 2020·Expert Opinion on Biological Therapy·Munjid Al HarthyRavi A Madan
Mar 5, 2020·Cancer Immunology, Immunotherapy : CII·Raquel TarazonaRafael Solana
Aug 3, 2019·International Journal of Cancer. Journal International Du Cancer·Emanuele PucaDario Neri
Mar 12, 2020·Expert Opinion on Biological Therapy·Karin M KnudsonSofia R Gameiro
Mar 7, 2020·Expert Review of Anticancer Therapy·Edgardo S Santos
Apr 4, 2020·American Society of Clinical Oncology Educational Book·Isabella Claudia GlitzaKim Margolin
Jun 13, 2019·Journal of Hematology & Oncology·Hao WangXingxing Zang
Jul 10, 2020·Expert Opinion on Investigational Drugs·Danilo RoccoCesare Gridelli
Jan 30, 2019·Scientific Reports·Gertrudis RojasKalet León
Jun 11, 2019·Frontiers in Oncology·Ondrej PalataIrena Adkins
Oct 16, 2019·The Journal of Experimental Medicine·Jonathan G PolGuido Kroemer
Nov 9, 2019·NPJ Breast Cancer·Margaret E Gatti-MaysElizabeth A Mittendorf
Jun 12, 2020·Cellular & Molecular Immunology·Jian Qiao, Yang-Xin Fu
Sep 17, 2020·Oncoimmunology·Julie Le NaourErika Vacchelli
Oct 4, 2017·Frontiers in Immunology·Mariana ArisMaría Marcela Barrio
Aug 15, 2018·Nature Materials·Hua Wang, David J Mooney
Nov 5, 2019·Frontiers in Oncology·Oliviero MarinelliMassimo Nabissi
Jun 4, 2020·Cellular Oncology (Dordrecht)·Jiao Wang, Sandro Matosevic
Dec 3, 2016·Science Translational Medicine·Natalia Arenas-RamirezOnur Boyman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

The Journal of Immunology : Official Journal of the American Association of Immunologists
Steven A Rosenberg
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Jennifer A WestwoodMichael H Kershaw
© 2021 Meta ULC. All rights reserved